According to the Oncomine database analysis by Metzeler et al., the MBD2 expression level in French–American–British (FAB) subtype M4/M5 AML cells is higher than that in granulocytes or monocytes from healthy donors or among cells of other subtypes of AML [14]. This evidence concerns the gene MBD2 and acute myeloid leukemia.